Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $18.60 million. The enterprise value is $2.80 million.

Market Cap	18.60M
Enterprise Value	2.80M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CGTX has 61.99 million shares outstanding. The number of shares has increased by 49.90% in one year.

Current Share Class	61.99M
Shares Outstanding	61.99M
Shares Change (YoY)	+49.90%
Shares Change (QoQ)	+38.38%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	9.09%
Float	55.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.52
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.05.

Current Ratio	2.09
Quick Ratio	1.94
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,681.95

Financial Efficiency

Return on equity (ROE) is -161.93% and return on invested capital (ROIC) is -156.66%.

Return on Equity (ROE)	-161.93%
Return on Assets (ROA)	-107.53%
Return on Invested Capital (ROIC)	-156.66%
Return on Capital Employed (ROCE)	-427.40%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.35% in the last 52 weeks. The beta is 0.74, so CGTX's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-82.35%
50-Day Moving Average	0.33
200-Day Moving Average	0.48
Relative Strength Index (RSI)	48.89
Average Volume (20 Days)	1,929,477

Short Selling Information

The latest short interest is 1.54 million, so 2.48% of the outstanding shares have been sold short.

Short Interest	1.54M
Short Previous Month	757,886
Short % of Shares Out	2.48%
Short % of Float	2.77%
Short Ratio (days to cover)	0.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.64M
Pretax Income	-31.08M
Net Income	-33.30M
EBITDA	-53.53M
EBIT	-53.64M
Earnings Per Share (EPS)	-$0.72

Full Income Statement

Balance Sheet

The company has $16.43 million in cash and $635,000 in debt, giving a net cash position of $15.79 million or $0.25 per share.

Cash & Cash Equivalents	16.43M
Total Debt	635,000
Net Cash	15.79M
Net Cash Per Share	$0.25
Equity (Book Value)	12.27M
Book Value Per Share	0.20
Working Capital	11.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.11 million and capital expenditures -$4,000, giving a free cash flow of -$31.11 million.

Operating Cash Flow	-31.11M
Capital Expenditures	-4,000
Free Cash Flow	-31.11M
FCF Per Share	-$0.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.90%
Shareholder Yield	-49.90%
Earnings Yield	-179.05%
FCF Yield	-167.28%

Analyst Forecast

The average price target for CGTX is $5.63, which is 1,776.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.63
Price Target Difference	1,776.67%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-28.28%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1